CYTK
CYTK
NASDAQ · Biotechnology

Cytokinetics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$53.69
-1.86 (-3.35%)
As of Nov 7, 1:22 AM ET ·
Analyst Consensus
Strong Buy
28
Analysts
High
Coverage
Buy 25 89%
Hold 3 11%
Sell 0 0%
Price Target
Analyst Price Target +48.6% upside
Low Target $53.35
Average Target $79.81
High Target $115.71
Current Price $53.69
Current
$53.69
Target
$79.81
$53.35 $79.81 avg $115.71
Scenario Analysis
Bear Case
$53.35
-0.6%
Low target
Base Case
$79.81
+48.6%
Avg target
Bull Case
$115.71
+115.5%
High target
Risk/Reward
182.4x
Highly favorable
Price in Context
52-Week High
$88.31
-39.2% from high
52-Week Low
$54.16
+-0.9% from low
50-Day SMA
$65.67
-18.2% vs SMA
200-Day SMA
$69.97
-23.3% vs SMA
RSI (14)
28.0
Oversold
Target vs 52W High
$79.81
-9.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.7%